RAUL ORTIZ DE LEJARAZU LEONARDO-rekin lankidetzan egindako argitalpenak (181)

2024

  1. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

  2. The role of viral diagnostic tests in respiratory tract infections: moving forward

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 252-256

2023

  1. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

    Frontiers in Immunology, Vol. 14

  2. Group 1 and group 2 hemagglutinin stalk antibody response according to age

    Frontiers in Immunology, Vol. 14

  3. Possible Mpox Protection from Smallpox Vaccine-Generated Antibodies among Older Adults

    Emerging Infectious Diseases, Vol. 29, Núm. 3, pp. 656-658

2022

  1. Coinfections of influenza and other respiratory viruses are associated to children

    Anales de Pediatria, Vol. 96, Núm. 4, pp. 334-341

2021

  1. Do Vaccines Need a Gender Perspective? Influenza Says Yes!

    Frontiers in Immunology, Vol. 12

  2. Global influenza surveillance in times of COVID-19: Robbing Peter to pay Paul?

    Revista Clinica Espanola

  3. Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses

    Frontiers in Microbiology, Vol. 12

  4. Social distancing, lockdown and thewide use of mask; a magic solution or a double-edged sword for respiratory viruses epidemiology?

    Vaccines, Vol. 9, Núm. 6

  5. Vigilancia de la gripe y otros virus respiratorios durante la pandemia de Covid-19, un enfoque One Health: la asignatura pendiente (2ª parte)

    Profesión veterinaria, Vol. 24, Núm. 96, pp. 59-70

2020

  1. 50 preguntas y respuestas sobre el coronavirus (Covid-19)

    Amazing Books

  2. Adjuvanted influenza vaccines elicits higher antibody responses against the A(H3N2) subtype than non-adjuvanted vaccines

    Vaccines, Vol. 8, Núm. 4, pp. 1-11

2019

  1. Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 5, pp. 1357-1362

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  3. Comparative study of the prevalence of the human papilloma virus in Spanish and foreign women participating in a population screening programme in Castilla y León

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 5, pp. 314-318

  4. Diagnostic challenges in influenza

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, pp. 47-55

  5. Epidemiological surveillance and wild-type MIC distribution of Legionella pneumophila in north-western Spain. 2003–2016

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 514-520

  6. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  7. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1